The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Anabolic steroid–induced hypogonadism: diagnosis and treatment
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Franke, W. W., & Berendonk, B. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1262 · Cited by 457
Nutritional supplements cross-contaminated and faked with doping substances
Geyer, H., Parr, M. K., Koehler, K., Mareck, U., Schänzer, W., & Thevis, M. (2008) · Journal of Mass Spectrometry · doi:10.1002/jms.1452 · Cited by 375
(2004) · International Journal of Sports Medicine · doi:10.1055/s-2004-819955 · Cited by 344
Liu, P. Y., Swerdloff, R. S., Christenson, P. D., Handelsman, D. J., & Wang, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68614-5 · Cited by 272
The insults of illicit drug use on male fertility
Fronczak, C. M., Kim, E. D., & Barqawi, A. B. (2012) · Journal of Andrology · doi:10.2164/jandrol.110.011874 · Cited by 217 · cited 3×
“Although several recent reviews have addressed the effects of androgen consumption on male fertility (6, 12, 29, 95, 96), some clinicians remain unaware of the fact that the use of exogenous androgens suppresses the HPG axis and, by decreasing intratesticular T (ITT), results in infertility (6, 97, 98).”
BackgroundSelf-citationVICARI, E., MONGIOÌ, A., CALOGERO, A. E., MONCADA, M. L., SIDOTI, G., POLOSA, P., & D'AGATA, R. (1992) · International Journal of Andrology · doi:10.1111/j.1365-2605.1992.tb01131.x · Cited by 145 · cited 1×
“Treatment with hCG is known to increase testicular volume, based on studies in patients with hypogonadotropic hypogonadism (105, 106).”
BackgroundBoccardo, F., Rubagotti, A., Battaglia, M., Di Tonno, P., Selvaggi, F. P., Conti, G., Comeri, G., Bertaccini, A., Martorana, G., Galassi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.013 · Cited by 145
Clomiphene citrate is safe and effective for long‐term management of hypogonadism
Moskovic, D. J., Katz, D. J., Akhavan, A., Park, K., & Mulhall, J. P. (2012) · BJU International · doi:10.1111/j.1464-410x.2012.10968.x · Cited by 136
The treatment of hypogonadism in men of reproductive age
Kim, E. D., Crosnoe, L., Bar-Chama, N., Khera, M., & Lipshultz, L. I. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.10.052 · Cited by 89
Self-citationTamoxifen for flutamide/finasteride-induced gynecomastia.
Staiman, V. R., & Lowe, F. C. (1997) · Urology · doi:10.1016/s0090-4295(97)00457-3 · Cited by 58
Research works printed but not linked: 97
- Borell, 1985, Organotherapy and the emergence of reproductive endocrinology, J Hist Biol, 18, 1, 10.1007/BF00127955 · DOI
- Brown-Séquard, 1893, On a new therapeutic method consisting in the use of organic liquids extracted from glands and other organs, Br Med J, 1, 1145, 10.1136/bmj.1.1692.1145 · doi:10.1136/bmj.1.1692.1145
- Brown-Séquard, 1889, The effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals, Lancet, 137, 105, 10.1016/S0140-6736(00)64118-1 · DOI · Paper page
- Foss, 1959, Oral methyltestosterone and jaundice, Br Med J, 1, 259, 10.1136/bmj.1.5117.259 · doi:10.1136/bmj.1.5117.259
- Foss, 1960, Some experiences with a new anabolic steroid (methandrostenolone), Br Med J, 1, 1300, 10.1136/bmj.1.5182.1300 · doi:10.1136/bmj.1.5182.1300
- Moss, 2013, Effect of rejuvenation hormones on spermatogenesis, Fertil Steril, 99, 1814, 10.1016/j.fertnstert.2013.04.003 · DOI
- Hartgens, 2004, Effects of androgenic-anabolic steroids in athletes, Sports Med, 34, 513, 10.2165/00007256-200434080-00003 · DOI · Paper page
- Kicman, 2008, Pharmacology of anabolic steroids, Br J Pharmacol, 154, 502, 10.1038/bjp.2008.165 · DOI · Paper page
- Parkinson, 2006, Anabolic androgenic steroids: a survey of 500 users, Med Sci Sports Exerc, 38, 644, 10.1249/01.mss.0000210194.56834.5d · DOI · Paper page
- Shahidi, 2001, A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids, Clin Ther, 23, 1355, 10.1016/S0149-2918(01)80114-4 · DOI · Paper page
- Casavant, 2007, Consequences of use of anabolic androgenic steroids, Pediatr Clin North Am, 54, 677, 10.1016/j.pcl.2007.04.001 · DOI
- Gårevik, 2011, Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids, J Steroid Biochem Mol Biol, 127, 295, 10.1016/j.jsbmb.2011.08.005 · DOI
- Kanayama, 2008, Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?, Drug Alcohol Depend, 98, 1, 10.1016/j.drugalcdep.2008.05.004 · DOI · Paper page
- Jarow, 1990, Anabolic steroid–induced hypogonadotropic hypogonadism, Am J Sports Med, 18, 429, 10.1177/036354659001800417 · DOI
- Coward, 2013, Anabolic steroid–induced hypogonadism in young men, J Urol, 190, 2200, 10.1016/j.juro.2013.06.010 · DOI
- Cohen, 2007, A league of their own: demographics, motivations and patterns of use of 1,955 male adult nonmedical anabolic steroid users in the United States, J Int Soc Sports Nutr, 4, 12, 10.1186/1550-2783-4-12 · DOI · Paper page
- Bauermeister, 2012, Innovative recruitment using online networks: lessons learned from an online study of alcohol and other drug use utilizing a web-based, respondent-driven sampling (webRDS) strategy, J Stud Alcohol Drugs, 73, 834, 10.15288/jsad.2012.73.834 · DOI · Paper page
- Evans, 1997, Gym and tonic: a profile of 100 male steroid users, Br J Sports Med, 31, 54, 10.1136/bjsm.31.1.54 · DOI · Paper page
- Hildebrandt, 2006, Predicting intentions for long-term anabolic-androgenic steroid use among men: a covariance structure model, Psychol Addict Behav, 20, 234, 10.1037/0893-164X.20.3.234 · DOI
- Ip, 2011, The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training, Pharmacotherapy, 31, 757, 10.1592/phco.31.8.757 · DOI
- McCabe, 2004, Comparison of web and mail surveys in collecting illicit drug use data: a randomized experiment, J Drug Educ, 34, 61, 10.2190/4HEY-VWXL-DVR3-HAKV · DOI
- McCabe, 2005, Mode effects for collecting alcohol and tobacco data among 3rd and 4th grade students: a randomized pilot study of Web-form versus paper-form surveys, Addict Behav, 30, 663, 10.1016/j.addbeh.2004.08.012 · DOI
- Miller, 2010, Using the Internet to research hidden populations of illicit drug users: a review, Addiction, 105, 1557, 10.1111/j.1360-0443.2010.02992.x · DOI · Paper page
- Perry, 1992, Dying to be big: a review of anabolic steroid use, Br J Sports Med, 26, 259, 10.1136/bjsm.26.4.259 · DOI
- Young, 2012, Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use, J Addict Dis, 31, 332, 10.1080/10550887.2012.735564 · DOI
- Sjöqvist, 2008, Use of doping agents, particularly anabolic steroids, in sports and society, Lancet, 371, 1872, 10.1016/S0140-6736(08)60801-6 · DOI · Paper page
- de Souza, 2011, Anabolic steroids and male infertility: a comprehensive review, BJU Int, 108, 1860, 10.1111/j.1464-410X.2011.10131.x · DOI · Paper page
- Kanayama, 2009, Anabolic-androgenic steroid dependence: an emerging disorder, Addiction, 104, 1966, 10.1111/j.1360-0443.2009.02734.x · DOI · Paper page
- Perry, 2005, Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization, Clin J Sport Med, 15, 326, 10.1097/01.jsm.0000180872.22426.bb · DOI
- Pirola, 2010, Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism, Fertil Steril, 94, 2331.e1, 10.1016/j.fertnstert.2010.03.042 · DOI
- Cooper, 2013, In vitro androgen bioassays as a detection method for designer androgens, Sensors, 13, 2148, 10.3390/s130202148 · DOI
- Cordaro, 2011, Selling androgenic anabolic steroids by the pound: identification and analysis of popular websites on the Internet, Scand J Med Sci Sports, 21, e247, 10.1111/j.1600-0838.2010.01263.x · DOI
- Baume, 2006, Research of stimulants and anabolic steroids in dietary supplements, Scand J Med Sci Sports, 16, 41, 10.1111/j.1600-0838.2005.00442.x · DOI
- Cavalcanti Gd, 2013, Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites, Steroids, 78, 228, 10.1016/j.steroids.2012.11.009 · DOI
- Parr, 2007, High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market, Biomed Chromatogr, 21, 164, 10.1002/bmc.728 · DOI
- Vilella, 2013, Cholestatic jaundice as a result of combination designer supplement ingestion, Ann Pharmacother, 47, e33, 10.1345/aph.1R405 · DOI
- Cohen, 2012, Assessing supplement safety—the FDA's controversial proposal, N Engl J Med, 366, 389, 10.1056/NEJMp1113325 · DOI
- Pope, 2004, Anabolic steroid users' attitudes toward physicians, Addiction, 99, 1189, 10.1111/j.1360-0443.2004.00781.x · DOI · Paper page
- Kanayama, 2012, Illicit use of androgens and other hormones: recent advances, Curr Opin Endocrinol Diabetes Obes, 19, 211, 10.1097/MED.0b013e3283524008 · DOI
- Tan, 2009, Anabolic steroid-induced hypogonadism—toward a unified hypothesis of anabolic steroid action, Med Hypotheses, 72, 723, 10.1016/j.mehy.2008.12.042 · DOI
- Boregowda, 2011, Persistent primary hypogonadism associated with anabolic steroid abuse, Fertil Steril, 96, e7, 10.1016/j.fertnstert.2011.04.029 · DOI
- Kanayama, 2009, Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence, Am J Psychiatry, 166, 642, 10.1176/appi.ajp.2009.08111699 · DOI
- Evans, 2004, Current concepts in anabolic-androgenic steroids, Am J Sports Med, 32, 534, 10.1177/0363546503262202 · DOI · Paper page
- Maravelias, 2005, Adverse effects of anabolic steroids in athletes. A constant threat, Toxicol Lett, 158, 167, 10.1016/j.toxlet.2005.06.005 · DOI · Paper page
- Moretti, 2007, Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids, J Assist Reprod Genet, 24, 195, 10.1007/s10815-005-9002-4 · doi:10.1007/s10815-005-9002-4
- Graham, 2008, Anabolic steroid use: patterns of use and detection of doping, Sports Med, 38, 505, 10.2165/00007256-200838060-00005 · DOI
- Arce, 1993, Exercise and male factor infertility, Sports Med, 15, 146, 10.2165/00007256-199315030-00002 · DOI
- Boettcher, 2011, Low-dose effects and biphasic effect profiles: is trenbolone a genotoxicant?, Mutat Res, 723, 152, 10.1016/j.mrgentox.2011.04.012 · DOI
- Chainy, 1997, Testosterone-induced changes in testicular antioxidant system, Andrologia, 29, 343, 10.1111/j.1439-0272.1997.tb00328.x · DOI · Paper page
- Karila, 2004, Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes, Int J Sports Med, 25, 257, 10.1055/s-2004-819936 · DOI
- Shokri, 2010, Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells, Basic Clin Pharmacol Toxicol, 106, 324, 10.1111/j.1742-7843.2009.00495.x · DOI
- Harkness, 1975, Effects of large doses of anabolic steroids, Br J Sports Med, 9, 70, 10.1136/bjsm.9.2.70 · doi:10.1136/bjsm.9.2.70
- Braunstein, 1999, Aromatase and gynecomastia, Endocr Relat Cancer, 6, 315, 10.1677/erc.0.0060315 · DOI · Paper page
- LeRoith, 1980, The effect of clomiphene citrate on pubertal gynaecomastia, Acta Endocrinol (Copenh), 95, 177
- Plourde, 1983, Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies, Am J Dis Child, 137, 1080, 10.1001/archpedi.1983.02140370040013 · DOI
- Serels, 1998, Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation, J Urol, 159, 1309, 10.1016/S0022-5347(01)63595-X · DOI
- Stepanas, 1977, Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report, J Pediatr, 90, 651, 10.1016/S0022-3476(77)80394-6 · DOI
- Bickelman, 1995, Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate, West J Med, 162, 158
- Menon, 2003, Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin, Fertil Steril, 79, 1659, 10.1016/S0015-0282(03)00365-0 · DOI
- Tan, 2003, Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse, Fertil Steril, 79, 203, 10.1016/S0015-0282(02)04550-8 · DOI
- Weinstein, 1974, Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism, J Clin Invest, 53, 408, 10.1172/JCI107574 · DOI
- de Luis, 2001, An Med Interna, 18, 489
- Braunstein, 2007, Clinical practice. Gynecomastia, N Engl J Med, 357, 1229, 10.1056/NEJMcp070677 · DOI · Paper page
- Ferrando, 2002, Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride, Arch Dermatol, 138, 543, 10.1001/archderm.138.4.533 · doi:10.1001/archderm.138.4.533
- Green, 1996, Gynecomastia and breast cancer during finasteride therapy, N Engl J Med, 335, 823, 10.1056/NEJM199609123351116 · DOI
- Lee, 2004, Male breast cancer during finasteride therapy, J Natl Cancer Inst, 96, 338, 10.1093/jnci/djh062 · DOI
- Traish, 2011, Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients, J Sex Med, 8, 872, 10.1111/j.1743-6109.2010.02157.x · DOI · Paper page
- Jameel, 2004, Gynaecomastia and the plant product “Tribulis terrestris”, Breast, 13, 428, 10.1016/j.breast.2003.10.013 · DOI
- Toorians, 2010, Gynaecomastia linked to the intake of a herbal supplement fortified with diethylstilbestrol, Food Addit Contam Part A Chem Anal Control, 27, 917, 10.1080/19440041003660869 · doi:10.1080/19440041003660869
- Deepinder, 2012, Drug-induced gynecomastia: an evidence-based review, Expert Opin Drug Saf, 11, 779, 10.1517/14740338.2012.712109 · DOI
- Dickson, 2012, Gynecomastia, Am Fam Physician, 85, 716
- Hanavadi, 2006, The role of tamoxifen in the management of gynaecomastia, Breast, 15, 276, 10.1016/j.breast.2005.04.007 · DOI
- Spano, 1984, Tamoxifen for gynecomastia induced by anabolic steroids?, N Engl J Med, 311, 861, 10.1056/NEJM198409273111323 · doi:10.1056/nejm198409273111323
- Babigian, 2001, Management of gynecomastia due to use of anabolic steroids in bodybuilders, Plast Reconstr Surg, 107, 240, 10.1097/00006534-200101000-00039 · doi:10.1097/00006534-200101000-00039
- Neild, 1995, Gynaecomastia in bodybuilders, Br J Clin Pract, 49, 172, 10.1111/j.1742-1241.1995.tb09941.x · doi:10.1111/j.1742-1241.1995.tb09941.x
- Lawrence, 2004, Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia, J Pediatr, 145, 71, 10.1016/j.jpeds.2004.03.057 · DOI
- Parker, 1986, Treatment of gynecomastia with tamoxifen: a double-blind crossover study, Metabolism, 35, 705, 10.1016/0026-0495(86)90237-4 · DOI
- Buvat, 1983, Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen, Fertil Steril, 39, 700, 10.1016/S0015-0282(16)47069-X · DOI
- de la Torre Abril, 2005, Arch Esp Urol, 58, 241
- Dony, 1985, Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men, Andrologia, 17, 369, 10.1111/j.1439-0272.1985.tb01024.x · DOI
- Tsourdi, 2009, The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia, Fertil Steril, 91, 1427, 10.1016/j.fertnstert.2008.06.002 · DOI
- Veldhuis, 1987, Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man, J Clin Invest, 80, 631, 10.1172/JCI113115 · DOI
- Vermeulen, 1978, Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men, Fertil Steril, 29, 320, 10.1016/S0015-0282(16)43160-2 · DOI
- Dohle, 2003, Androgens and male fertility, World J Urol, 21, 341, 10.1007/s00345-003-0365-9 · DOI · Paper page
- Lombardo, 2005, Androgens and fertility, J Endocrinol Invest, 28, 51
- Bagatell, 1996, Androgens in men—uses and abuses, N Engl J Med, 334, 707, 10.1056/NEJM199603143341107 · DOI · Paper page
- Ko, 2012, Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association, J Urol, 187, 973, 10.1016/j.juro.2011.10.137 · DOI · Paper page
- Basaria, 2010, Androgen abuse in athletes: detection and consequences, J Clin Endocrinol Metab, 95, 1533, 10.1210/jc.2009-1579 · DOI · Paper page
- Gazvani, 1997, Conservative management of azoospermia following steroid abuse, Hum Reprod, 12, 1706, 10.1093/humrep/12.8.1706 · DOI
- Knuth, 1989, Anabolic steroids and semen parameters in bodybuilders, Fertil Steril, 52, 1041, 10.1016/S0015-0282(16)53172-0 · DOI
- Turek, 1995, The reversibility of anabolic steroid-induced azoospermia, J Urol, 153, 1628, 10.1016/S0022-5347(01)67482-2 · DOI
- Grokett, 1992, The effects of an anabolic steroid (oxandrolone) on reproductive development in the male rat, Acta Endocrinol (Copenh), 126, 173
- Hsieh, 2013, Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy, J Urol, 189, 647, 10.1016/j.juro.2012.09.043 · DOI
- Kim, 2011, Penile growth in response to human chorionic gonadotropin (hCG) treatment in patients with idiopathic hypogonadotrophic hypogonadism, Chonnam Med J, 47, 39, 10.4068/cmj.2011.47.1.39 · DOI
- Gardner, 1968, The erythrocythaemic effects of androgen, Br J Haematol, 14, 611, 10.1111/j.1365-2141.1968.tb00367.x · DOI
- Gooren, 2010, Androgens and male aging: current evidence of safety and efficacy, Asian J Androl, 12, 136, 10.1038/aja.2010.4 · DOI
- Stergiopoulos, 2008, Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature, Vasc Health Risk Manag, 4, 1475, 10.2147/VHRM.S4261 · DOI
Cited by
Eisenberg, M. L., Esteves, S. C., Lamb, D. J., Hotaling, J. M., Giwercman, A., Hwang, K., & Cheng, Y.-S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00459-w · Cited by 536
Lifestyle causes of male infertility
Durairajanayagam, D. (2018) · Arab Journal of Urology · doi:10.1016/j.aju.2017.12.004 · Cited by 411
Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review
Albano, G. D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., Rosi, G. L., Di Nunno, N., Salerno, M., & Montana, A. (2021) · Healthcare · doi:10.3390/healthcare9010097 · Cited by 200
“Management strategies for male infertility secondary to AAS induced hypogonadism should focus on the underlying hypogonadal state [105,106].”
BackgroundChristou, M. A., Christou, P. A., Markozannes, G., Tsatsoulis, A., Mastorakos, G., & Tigas, S. (2017) · Sports Medicine · doi:10.1007/s40279-017-0709-z · Cited by 199
“It is possible that shorter duration of AAS use, lower AAS doses, younger age of the athletes and higher testosterone levels at baseline, are associated with a more “elastic axis”, capable of recovering GnRH pulsation and gonadotropin secretion faster and more completely [57].”
BackgroundSociety for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
Metadata
- Authors
- Rahnema, C. D., Lipshultz, L. I., Crosnoe, L. E., Kovac, J. R., & Kim, E. D.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 101
- Issue
- 5
- Pages
- 1271-1279
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2143638407
- Cited by
- 251
- References
- 11
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2948 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.